Bruker Shares Drop on Reduced Q2 Estimates | GenomeWeb

NEW YORK, July 15 (GenomeWeb News) - Bruker BioSciences today announced that it expects its second quarter revenues to fall short of earlier predictions, causing shares of the Billerica, Mass.-based company to fall 10 percent in early afternoon trading on the NASDAQ.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.